Author Archives: Isaura Santos

Mike Nace, Editor-in-Chief of Multiple Sclerosis News Today, Reviews Day 1 at #ECTRIMS2015

http://multiplesclerosisnewstoday.com/wp-content/uploads/2015/10/ECTRIMS-Podcast-1-081015-1.53-pm.m4a Read the articles mentioned in the podcast: ECTRIMS 2015 Congress: a Look at Young Investigator Session I ECTRIMS 2015 Congress: a Look at Young Investigator Session II Icometrix Collaborates with Novartis on MSmetrix Software Application, New Data at Upcoming ECTRIMS 2015 Conference Genzyme to…

#ECTRIMS2015 – What Would You Like To Ask Genentech?

  This year, Multiple Sclerosis News Today will be offering live, on-site coverage of the ECTRIMS conference in Barcelona Spain. Dr. Ana de Barros, PhD is attending the conference as the site’s correspondent and will have the opportunity to interview Genentech representatives on their recent breakthroughs in MS. In an effort to connect our…

10 Must-Read Articles For #ECTRIMS2015

Here is what you need to read before #ECTRIMS2015 1.       Could Genentech’s Ocrelizumab Become the First Effective Primary Progressive MS Therapy?   2.      Ocrelizumab: a Promising New Treatment for Multiple Sclerosis with Minimal Side Effects   3.      Roche’s Ocrelizumab Found to be Superior to…

MS News Today at #ECTRIMS2015

Tune in to MS News Today for full, on-site coverage of ECTRIMS 2015. Join us on twitter @MSNewsToday and keep track of these hashtags: #ECTRIMS2015 / #MSNewsToday  Facebook: http://on.fb.me/1FLwA11…

1200 People With Relapsing MS Needed For RPC1063, Avonex Clinical Trials

Clinical investigators worldwide are beginning to recruit 1,200 patients with relapsing multiple sclerosis for a study assessing the effectiveness of two different doses of RPC1063 (Receptos, Inc.), an experimental oral therapy, and Avonex® (interferon beta-1a, Biogen Inc.) in order to reduce relapse rate in patients. This study, called the Sunbeam Study, is being funded by…

Report Shows MS Patients Miss Out On Access To Palliative Care Services

A recent report by Marie Curie fellows organization suggests that those suffering from neurological conditions such as multiple sclerosis are missing out on care that could make a major difference in the quality of their lives. When it comes to palliative care, the report contends that there is a limited understanding about the need…

Multiple Sclerosis Patients Could One Day Benefit From Brain Boost Study

A recent study suggests that in the future multiple sclerosis patients could benefit from treatments intended to boost their brain function. The study was published in Nature Neuroscience and received funding from The Wellcome Trust, the Lister Research Prize and the Biotechnology and Biological Sciences Research Council. According to researchers, patients…

‘Treat Me Right’ MS Society Campaign Shortlisted For Award

The Treat Me Right campaign from the MS Society in the UK was recently shortlisted for this year’s voluntary sector campaign Public Affairs Award. The campaign was launched in April 2014 during MS Week to raise awareness for the importance of providing the right treatment at the right moment…

Dancing Doodle

Did you know some of the news and columns on Multiple Sclerosis News Today are recorded and available for listening on SoundCloud? These flash briefings give our readers an alternative option for accessing information important for them.

Listen Here

Video